PWUPU

Aspire Biopharma Holdings, Inc.

A biopharmaceutical company developing a sublingual (under-the-tongue) drug delivery platform that lets medications and supplements absorb quickly into the bloodstream, skipping the stomach and liver. Founded in 2021, it came to life when the earlier shell company PowerUp Acquisition Corp. merged with it in early 2025 and the combined business took the name Aspire. The name "Aspire" nods to ambition, though the company has never spelled out a story behind it—a small mystery fans of naming lore can chew on.

UNITUnderlying: ASBPISIN: KYG7207P1110HealthcareUS1 holder

Units consisting of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant exercisable for one Class A ordinary share at 1.50

Ownership Activity Financials Filings

PWUPU

PWUPU

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Other Events

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Other Events

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Regulation FD Disclosure